Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Illumina wins patent infringement suit against BGI in U.K. » 16:06
01/20/21
01/20
16:06
01/20/21
16:06
ILMN

Illumina

$402.10 /

+11.62 (+2.98%)

The company states:…

The company states: "Illumina announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. Courts in the US, Germany, Spain, Finland and Sweden have issued injunctions against BGI. The Court had previously issued a preliminary injunction against BGI's UK-based sequencing laboratory and restricted BGI's ability to supply the infringing sequencing systems in the UK. Illumina intends to seek a permanent injunction fully prohibiting the supply or sale of BGI's StandardMPS and CoolMPS systems in the UK until the relevant patents expire. Additional lawsuits are pending in Hong Kong S.A.R., France, Belgium, Denmark, Switzerland, Turkey and Italy."

ShowHide Related Items >><<
ILMN Illumina
$402.10 /

+11.62 (+2.98%)

ILMN Illumina
$402.10 /

+11.62 (+2.98%)

12/22/20
Fly Intel: Top five analyst upgrades
12/22/20 OTR Global
Illumina upgraded to Positive from Mixed at OTR Global
12/22/20 Piper Sandler
Illumina upgraded to Overweight from Neutral at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
ILMN Illumina
$402.10 /

+11.62 (+2.98%)

ILMN Illumina
$402.10 /

+11.62 (+2.98%)

ILMN Illumina
$402.10 /

+11.62 (+2.98%)

ILMN Illumina
$402.10 /

+11.62 (+2.98%)

Recommendations
1Life Healthcare jumps after William Blair sees vaccine rollout benefits » 09:45
01/20/21
01/20
09:45
01/20/21
09:45
ONEM

1Life Healthcare

$50.37 /

+2.68 (+5.62%)

William Blair analyst…

William Blair analyst Ryan Daniels sees 1Life Healthcare as a potential derivative beneficiary from the administration of Covid-19 vaccines. The company's support for vaccines in New York, Seattle and the San Francisco area, coupled with its plans to provide complimentary services to qualifying patients, could increase sales from vaccinations and "serve as a bit of a Trojan-horse marketing campaign to acquire new members," Daniels told investors earlier in a research note. The analyst keeps an Outperform rating on the shares. 1Life Healthcare in early trading is 9%, or $4.51, to $52.22.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$50.37 /

+2.68 (+5.62%)

ONEM 1Life Healthcare
$50.37 /

+2.68 (+5.62%)

01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21 Piper Sandler
1Life Healthcare price target raised to $51 from $44 at Piper Sandler
01/07/21 Canaccord
1Life Healthcare price target raised to $50 from $46 at Canaccord
01/06/21 BTIG
1Life Healthcare initiated with a Neutral at BTIG
ONEM 1Life Healthcare
$50.37 /

+2.68 (+5.62%)

  • 23
    Nov
  • 25
    Jun
  • 31
    Jan
ONEM 1Life Healthcare
$50.37 /

+2.68 (+5.62%)

ONEM 1Life Healthcare
$50.37 /

+2.68 (+5.62%)

Tuesday
On The Fly
Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades » 15:26
01/19/21
01/19
15:26
01/19/21
15:26
ADPT

Adaptive Biotechnologies

$67.13 /

+2.2 (+3.39%)

, REVG

REV Group

$10.64 /

+1.52 (+16.67%)

, CCEL

Cryo-Cell

$0.00 /

+ (+0.00%)

, SPLP

Steel Partners

$13.78 /

+0.43 (+3.22%)

, RILY

B. Riley Financial

$48.82 /

-0.84 (-1.69%)

, FB

Facebook

$261.66 /

+10.13 (+4.03%)

, NBIX

Neurocrine

$108.28 /

+0.37 (+0.34%)

, ONEM

1Life Healthcare

$47.03 /

+4.385 (+10.28%)

 Welcome to "Fly…

ShowHide Related Items >><<
SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
11/12/20 BTIG
Adaptive Biotechnologies price target raised to $63 from $60 at BTIG
11/11/20 JPMorgan
Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan
REVG REV Group
$10.64 /

+1.52 (+16.67%)

01/08/21 Baird
REV Group result pretty much as expected, says Baird
12/17/20 Baird
REV Q4 results delay could portend impending portfolio realignment, says Baird
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight on improved RV outlook at Morgan Stanley
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight from Underweight at Morgan Stanley
CCEL Cryo-Cell
$0.00 /

+ (+0.00%)

SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
01/19/21 BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

12/29/20 Cantor Fitzgerald
Neurocrine price target lowered to $121 from $168 at Cantor Fitzgerald
12/07/20 Wedbush
Neurocrine price target lowered to $121 from $129 at Wedbush
11/12/20 Canaccord
Neurocrine price target lowered to $122 from $145 at Canaccord
11/10/20 SVB Leerink
Neurocrine price target lowered to $100 from $120 at SVB Leerink
ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21 Piper Sandler
1Life Healthcare price target raised to $51 from $44 at Piper Sandler
01/07/21 Canaccord
1Life Healthcare price target raised to $50 from $46 at Canaccord
01/06/21 BTIG
1Life Healthcare initiated with a Neutral at BTIG
SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

  • 13
    Jan
  • 23
    Nov
  • 16
    Jul
  • 25
    Jun
  • 24
    Jan
  • 31
    Jan
FB Facebook
$261.66 /

+10.13 (+4.03%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

Recommendations
Teladoc remains top 2021 healthcare technology pick at JPMorgan » 10:07
01/19/21
01/19
10:07
01/19/21
10:07
TDOC

Teladoc

$227.20 /

+1.965 (+0.87%)

, CVS

CVS Health

$76.19 /

-0.07 (-0.09%)

, ONEM

1Life Healthcare

$42.98 /

+0.335 (+0.79%)

Coming out of her…

Coming out of her firm's healthcare conference last week, JPMorgan analyst Lisa Gill says Teladoc Health (TDOC) remains her top pick for 2021 in the healthcare technology and distribution sector. The analyst also highlights CVS Health (CVS) as her top value idea and 1Life Healthcare (ONEM) as her top "SMID idea." Gill continues to expect these companies to be beneficiaries of the key themes for 2021: consumerism, specialty/biosimilars, COVID-19 vaccine/testing and capital deployment.

ShowHide Related Items >><<
TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

ONEM 1Life Healthcare
$42.98 /

+0.335 (+0.79%)

CVS CVS Health
$76.19 /

-0.07 (-0.09%)

TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

01/15/21 Benchmark
SOC Telemed initiated with a Buy at Benchmark
01/12/21 BTIG
Teladoc price target raised to $260 from $240 at BTIG
01/12/21 Piper Sandler
Teladoc visibility improving, fundamentals attractive, says Piper Sandler
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
CVS CVS Health
$76.19 /

-0.07 (-0.09%)

01/08/21
Fly Intel: Top five analyst upgrades
01/08/21 Jefferies
CVS Health upgraded to Buy on COVID-19 vaccination upside at Jefferies
01/08/21 Jefferies
CVS Health upgraded to Buy from Hold at Jefferies
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
ONEM 1Life Healthcare
$42.98 /

+0.335 (+0.79%)

01/08/21 Piper Sandler
1Life Healthcare price target raised to $51 from $44 at Piper Sandler
01/07/21 Canaccord
1Life Healthcare price target raised to $50 from $46 at Canaccord
01/06/21 BTIG
1Life Healthcare initiated with a Neutral at BTIG
12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

ONEM 1Life Healthcare
$42.98 /

+0.335 (+0.79%)

CVS CVS Health
$76.19 /

-0.07 (-0.09%)

  • 23
    Nov
  • 25
    Jun
  • 31
    Jan
TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

CVS CVS Health
$76.19 /

-0.07 (-0.09%)

TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

ONEM 1Life Healthcare
$42.98 /

+0.335 (+0.79%)

CVS CVS Health
$76.19 /

-0.07 (-0.09%)

TDOC Teladoc
$227.20 /

+1.965 (+0.87%)

ONEM 1Life Healthcare
$42.98 /

+0.335 (+0.79%)

CVS CVS Health
$76.19 /

-0.07 (-0.09%)

Options
Unusual call flow in option market yesterday » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
SLQT

SelectQuote

$23.55 /

+0.98 (+4.34%)

Notable call activity was…

Notable call activity was cited Friday in SelectQuote (SLQT).

ShowHide Related Items >><<
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

  • 21
    May
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

Over a week ago
Options
SelectQuote call buyer as shares jump » 11:20
01/15/21
01/15
11:20
01/15/21
11:20
SLQT

SelectQuote

$23.13 /

+0.56 (+2.48%)

SelectQuote call buyer as…

SelectQuote call buyer as shares jump. Shares of the direct to consumer insurance company up 36c, or 1.6%, near $23 this morning after a call buyer snapped up nearly 3k Feb 25 calls, starting with a 70c sweep of 234 and cleaning up with a 2167 lot on the Phlx for 85c. Opens a new position that is sized nearly 4x the average daily call volume in the name. Earnings Feb 4th.

ShowHide Related Items >><<
SLQT SelectQuote
$23.13 /

+0.56 (+2.48%)

SLQT SelectQuote
$23.13 /

+0.56 (+2.48%)

10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
SLQT SelectQuote
$23.13 /

+0.56 (+2.48%)

  • 21
    May
SLQT SelectQuote
$23.13 /

+0.56 (+2.48%)

Options
Early notable gainers among liquid option names on January 15th » 09:55
01/15/21
01/15
09:55
01/15/21
09:55
ILMN

Illumina

$381.08 /

+9.76 (+2.63%)

, PCG

PG&E

$12.08 /

+0.245 (+2.07%)

, RRC

Range Resources

$10.25 /

+0.29 (+2.91%)

, AKAM

Akamai

$104.70 /

+1.82 (+1.77%)

, EQT

EQT Corporation

$18.18 /

+0.27 (+1.51%)

Notable gainers among…

Notable gainers among liquid option names this morning include Illumina (ILMN) $390.23 +18.86, PG&E (PCG) $12.32 +0.49, Range Resources (RRC) $10.28 +0.32, Akamai (AKAM) $105.94 +3.01, and EQT Corporation (EQT) $18.39 +0.49.

ShowHide Related Items >><<
RRC Range Resources
$10.25 /

+0.29 (+2.91%)

PCG PG&E
$12.08 /

+0.245 (+2.07%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

AKAM Akamai
$104.70 /

+1.82 (+1.77%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

12/22/20
Fly Intel: Top five analyst upgrades
12/22/20 OTR Global
Illumina upgraded to Positive from Mixed at OTR Global
12/22/20 Piper Sandler
Illumina upgraded to Overweight from Neutral at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
PCG PG&E
$12.08 /

+0.245 (+2.07%)

01/06/21 Wells Fargo
Wells Fargo says buy CenterPoint Energy, sell FirstEnergy
01/06/21 Wells Fargo
PG&E downgraded to Underweight from Equal Weight at Wells Fargo
11/18/20 Barclays
PG&E price target raised to $14 from $13 at Barclays
11/12/20 Wolfe Research
PG&E upgraded to Outperform from Peer Perform at Wolfe Research
RRC Range Resources
$10.25 /

+0.29 (+2.91%)

01/12/21 Tudor Pickering
Range Resources upgraded to Buy from Hold at Tudor Pickering
01/11/21 Mizuho
Range Resources price target lowered to $9 from $12 at Mizuho
01/06/21 BofA
Range Resources downgraded to Neutral from Buy at BofA
12/11/20 Morgan Stanley
Morgan Stanley upgrades E&P industry to Attractive, raises ratings on 3 stocks
AKAM Akamai
$104.70 /

+1.82 (+1.77%)

11/12/20 Piper Sandler
Akamai price target lowered to $120 from $125 at Piper Sandler
10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
10/15/20 Piper Sandler
Piper says buy Akamai, Cloudflare on Fastly related selloff
10/08/20 FBN Securities
Cloudflare initiated with an Outperform at FBN Securities
EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
12/15/20
Fly Intel: Top five analyst initiations
12/15/20 BofA
EQT Corporation initiated with a Buy at BofA
12/08/20 JPMorgan
EQT Corporation downgraded to Neutral with $17 target at JPMorgan
RRC Range Resources
$10.25 /

+0.29 (+2.91%)

PCG PG&E
$12.08 /

+0.245 (+2.07%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

AKAM Akamai
$104.70 /

+1.82 (+1.77%)

  • 28
    Oct
  • 26
    Jun
PCG PG&E
$12.08 /

+0.245 (+2.07%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

RRC Range Resources
$10.25 /

+0.29 (+2.91%)

PCG PG&E
$12.08 /

+0.245 (+2.07%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

AKAM Akamai
$104.70 /

+1.82 (+1.77%)

RRC Range Resources
$10.25 /

+0.29 (+2.91%)

PCG PG&E
$12.08 /

+0.245 (+2.07%)

ILMN Illumina
$381.08 /

+9.76 (+2.63%)

EQT EQT Corporation
$18.18 /

+0.27 (+1.51%)

AKAM Akamai
$104.70 /

+1.82 (+1.77%)

Conference/Events
JPMorgan to hold a virtual conference » 04:55
01/14/21
01/14
04:55
01/14/21
04:55
ABMD

Abiomed

$323.77 /

-1.24 (-0.38%)

, AGIO

Agios Pharmaceuticals

$46.48 /

-0.06 (-0.13%)

, AHCO

AdaptHealth

$36.94 /

+0.165 (+0.45%)

, BCAB

BioAtla

$44.92 /

+3.54 (+8.55%)

, NXGN

NextGen Healthcare

$21.27 /

+0.79 (+3.86%)

, OLMA

Olema Oncology

$41.90 /

-0.07 (-0.17%)

, PCRX

Pacira

$73.50 /

+0.39 (+0.53%)

, BIIB

Biogen

$266.71 /

-0.81 (-0.30%)

, ESPR

Esperion

$26.94 /

-3.335 (-11.02%)

, EXEL

Exelixis

$24.38 /

-0.845 (-3.35%)

, HQY

HealthEquity

$75.73 /

-0.25 (-0.33%)

, MORF

Morphic Holding

$30.30 /

+0.29 (+0.97%)

, NNOX

Nano-X Imaging

$54.30 /

+2.66 (+5.15%)

, SRPT

Sarepta

$87.22 /

+0.03 (+0.03%)

, SHC

Sotera Health

$25.01 /

-0.19 (-0.75%)

, RVNC

Revance

$29.02 /

-0.45 (-1.53%)

, RUBY

Rubius Therapeutics

$8.89 /

-0.28 (-3.05%)

, ZYME

Zymeworks

$52.97 /

-0.87 (-1.62%)

39th Annual Healthcare…

39th Annual Healthcare Virtual Conference will be held on January 11-14.

ShowHide Related Items >><<
ZYME Zymeworks
$52.97 /

-0.87 (-1.62%)

SRPT Sarepta
$87.22 /

+0.03 (+0.03%)

SHC Sotera Health
$25.01 /

-0.19 (-0.75%)

RVNC Revance
$29.02 /

-0.45 (-1.53%)

RUBY Rubius Therapeutics
$8.89 /

-0.28 (-3.05%)

PCRX Pacira
$73.50 /

+0.39 (+0.53%)

NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

MORF Morphic Holding
$30.30 /

+0.29 (+0.97%)

HQY HealthEquity
$75.73 /

-0.25 (-0.33%)

EXEL Exelixis
$24.38 /

-0.845 (-3.35%)

ESPR Esperion
$26.94 /

-3.335 (-11.02%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

AHCO AdaptHealth
$36.94 /

+0.165 (+0.45%)

AGIO Agios Pharmaceuticals
$46.48 /

-0.06 (-0.13%)

ABMD Abiomed
$323.77 /

-1.24 (-0.38%)

ABMD Abiomed
$323.77 /

-1.24 (-0.38%)

12/21/20 SVB Leerink
Abiomed price target raised to $320 from $280 at SVB Leerink
12/14/20 Piper Sandler
Abiomed gets approval for XR sheath, says Piper Sandler
10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
08/07/20 SVB Leerink
Abiomed price target raised to $335 from $280 at SVB Leerink
AGIO Agios Pharmaceuticals
$46.48 /

-0.06 (-0.13%)

12/23/20 Citi
Agios shares 'significantly undervalued at this point,' says Citi
12/22/20 SVB Leerink
Agios Pharmaceuticals price target lowered to $51 from $61 at SVB Leerink
12/22/20 Cantor Fitzgerald
Agios oncology deal a positive read to FT-4202 strategy, says Cantor Fitzgerald
12/22/20 Barclays
Agios could enter 2022 with a third fewer shares, says Barclays
AHCO AdaptHealth
$36.94 /

+0.165 (+0.45%)

01/07/21 Canaccord
AdaptHealth price target raised to $50 from $39 at Canaccord
12/10/20 UBS
AdaptHealth initiated with a Buy at UBS
12/04/20 Deutsche Bank
AdaptHealth price target raised to $47 from $36 at Deutsche Bank
12/02/20 SVB Leerink
AdaptHealth price target raised to $39.50 from $32.50 at SVB Leerink
BCAB BioAtla
$44.92 /

+3.54 (+8.55%)

01/11/21 JPMorgan
BioAtla initiated with an Overweight at JPMorgan
01/11/21 Credit Suisse
BioAtla initiated with an Outperform at Credit Suisse
01/11/21 Jefferies
BioAtla initiated with a Buy at Jefferies
01/11/21 BTIG
BioAtla initiated with a Buy at BTIG
NXGN NextGen Healthcare
$21.27 /

+0.79 (+3.86%)

10/23/20 SVB Leerink
NextGen Healthcare price target raised to $14 from $12 at SVB Leerink
10/23/20 Piper Sandler
NextGen Healthcare price target lowered to $21 from $23 at Piper Sandler
07/31/20 Piper Sandler
NextGen Healthcare price target raised to $23 from $17 at Piper Sandler
06/02/20 Deutsche Bank
NextGen Healthcare price target lowered to $9 from $12 at Deutsche Bank
OLMA Olema Oncology
$41.90 /

-0.07 (-0.17%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
PCRX Pacira
$73.50 /

+0.39 (+0.53%)

01/06/21 RBC Capital
Pacira price target raised to $70 at RBC Capital, named one of 2021 top ideas
12/14/20 Barclays
Pacira price target raised to $79 from $73 at Barclays
09/30/20 Jefferies
Pacira price target raised to $75 from $69 at Jefferies
09/21/20 Northland
Pacira upgraded to Outperform on Exparel sales expectations at Northland
BIIB Biogen
$266.71 /

-0.81 (-0.30%)

01/11/21 Goldman Sachs
Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
12/04/20 Mizuho
Sage Therapeutics upgraded to Buy from Neutral at Mizuho
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
ESPR Esperion
$26.94 /

-3.335 (-11.02%)

11/10/20 Credit Suisse
Esperion upgraded to Outperform from Neutral at Credit Suisse
09/29/20 JPMorgan
Esperion resumed with an Underweight at JPMorgan
08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
EXEL Exelixis
$24.38 /

-0.845 (-3.35%)

12/14/20 William Blair
Calithera risk/reward attractive into CANTATA readout, says William Blair
10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
HQY HealthEquity
$75.73 /

-0.25 (-0.33%)

01/06/21 BTIG
HealthEquity initiated with a Neutral at BTIG
01/06/21 Deutsche Bank
HealthEquity price target raised to $77 from $60 at Deutsche Bank
12/08/20 Cantor Fitzgerald
HealthEquity price target raised to $77 from $70 at Cantor Fitzgerald
12/08/20 JPMorgan
HealthEquity price target raised to $72 from $61 at JPMorgan
MORF Morphic Holding
$30.30 /

+0.29 (+0.97%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

09/15/20 Cantor Fitzgerald
Cantor reiterates $70 target on Nano-X after 'unfounded' short report
09/15/20 Cantor Fitzgerald
Nano-X Imaging concerns in short report unfounded, says Cantor Fitzgerald
09/15/20 Oppenheimer
Nano-X Imaging initiated with a Perform at Oppenheimer
09/15/20 Berenberg
Nano-X Imaging initiated with a Buy at Berenberg
SRPT Sarepta
$87.22 /

+0.03 (+0.03%)

01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
01/11/21
Fly Intel: Top five analyst downgrades
01/11/21 UBS
Sarepta downgraded to Neutral on 'unexpected negative' results at UBS
01/11/21 UBS
Sarepta downgraded to Neutral from Buy at UBS
SHC Sotera Health
$25.01 /

-0.19 (-0.75%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
RVNC Revance
$29.02 /

-0.45 (-1.53%)

12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
11/25/20 H.C. Wainwright
H.C. Wainwright keeps Buy rating on Revance, says FDA news 'not surprising'
11/10/20 Mizuho
Revance price target lowered to $30 from $32 at Mizuho
10/26/20 Barclays
Revance price target raised to $38 from $35 at Barclays
RUBY Rubius Therapeutics
$8.89 /

-0.28 (-3.05%)

10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
ZYME Zymeworks
$52.97 /

-0.87 (-1.62%)

01/12/21 SVB Leerink
Zymeworks price target raised to $66 from $45 at SVB Leerink
01/12/21 Wells Fargo
Zymeworks price target raised to $71 from $58 at Wells Fargo
09/29/20 JPMorgan
Zymeworks resumed with a Neutral at JPMorgan
08/06/20
Fly Intel: Top analyst initiations
ZYME Zymeworks
$52.97 /

-0.87 (-1.62%)

SRPT Sarepta
$87.22 /

+0.03 (+0.03%)

SHC Sotera Health
$25.01 /

-0.19 (-0.75%)

RVNC Revance
$29.02 /

-0.45 (-1.53%)

RUBY Rubius Therapeutics
$8.89 /

-0.28 (-3.05%)

PCRX Pacira
$73.50 /

+0.39 (+0.53%)

NXGN NextGen Healthcare
$21.27 /

+0.79 (+3.86%)

NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

MORF Morphic Holding
$30.30 /

+0.29 (+0.97%)

HQY HealthEquity
$75.73 /

-0.25 (-0.33%)

EXEL Exelixis
$24.38 /

-0.845 (-3.35%)

ESPR Esperion
$26.94 /

-3.335 (-11.02%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

AHCO AdaptHealth
$36.94 /

+0.165 (+0.45%)

AGIO Agios Pharmaceuticals
$46.48 /

-0.06 (-0.13%)

ABMD Abiomed
$323.77 /

-1.24 (-0.38%)

  • 06
    Jan
  • 15
    Dec
  • 16
    Dec
  • 19
    Nov
  • 20
    Nov
  • 03
    Sep
  • 21
    Aug
  • 09
    Jul
  • 01
    Jul
  • 12
    Feb
  • 23
    Jan
NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

SRPT Sarepta
$87.22 /

+0.03 (+0.03%)

RVNC Revance
$29.02 /

-0.45 (-1.53%)

OLMA Olema Oncology
$41.90 /

-0.07 (-0.17%)

NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

HQY HealthEquity
$75.73 /

-0.25 (-0.33%)

ESPR Esperion
$26.94 /

-3.335 (-11.02%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

BCAB BioAtla
$44.92 /

+3.54 (+8.55%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

NNOX Nano-X Imaging
$54.30 /

+2.66 (+5.15%)

HQY HealthEquity
$75.73 /

-0.25 (-0.33%)

ESPR Esperion
$26.94 /

-3.335 (-11.02%)

BIIB Biogen
$266.71 /

-0.81 (-0.30%)

AHCO AdaptHealth
$36.94 /

+0.165 (+0.45%)

Conference/Events
JPMorgan to hold a virtual conference » 04:55
01/13/21
01/13
04:55
01/13/21
04:55
ABMD

Abiomed

$324.65 /

+0.28 (+0.09%)

, AGIO

Agios Pharmaceuticals

$46.54 /

-0.19 (-0.41%)

, AHCO

AdaptHealth

$36.78 /

-0.405 (-1.09%)

, BCAB

BioAtla

$41.38 /

+1.38 (+3.45%)

, NXGN

NextGen Healthcare

$20.50 /

+0.89 (+4.54%)

, OLMA

Olema Oncology

$41.97 /

+0.84 (+2.04%)

, PCRX

Pacira

$73.11 /

+1.46 (+2.04%)

, BIIB

Biogen

$267.44 /

-0.13 (-0.05%)

, ESPR

Esperion

$30.28 /

-1.01 (-3.23%)

, EXEL

Exelixis

$25.23 /

+1.1 (+4.56%)

, HQY

HealthEquity

$75.95 /

+1.83 (+2.47%)

, MORF

Morphic Holding

$30.12 /

+0.27 (+0.90%)

, NNOX

Nano-X Imaging

$51.61 /

+0.22 (+0.43%)

, SRPT

Sarepta

$87.32 /

-2.46 (-2.74%)

, SHC

Sotera Health

$25.20 /

-0.39 (-1.52%)

, RVNC

Revance

$29.47 /

+0.46 (+1.59%)

, RUBY

Rubius Therapeutics

$9.16 /

+0.12 (+1.33%)

, ZYME

Zymeworks

$53.99 /

-2.49 (-4.41%)

39th Annual Healthcare…

39th Annual Healthcare Virtual Conference will be held on January 11-14.

ShowHide Related Items >><<
ZYME Zymeworks
$53.99 /

-2.49 (-4.41%)

SRPT Sarepta
$87.32 /

-2.46 (-2.74%)

SHC Sotera Health
$25.20 /

-0.39 (-1.52%)

RVNC Revance
$29.47 /

+0.46 (+1.59%)

RUBY Rubius Therapeutics
$9.16 /

+0.12 (+1.33%)

PCRX Pacira
$73.11 /

+1.46 (+2.04%)

NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

MORF Morphic Holding
$30.12 /

+0.27 (+0.90%)

HQY HealthEquity
$75.95 /

+1.83 (+2.47%)

EXEL Exelixis
$25.23 /

+1.1 (+4.56%)

ESPR Esperion
$30.28 /

-1.01 (-3.23%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

AHCO AdaptHealth
$36.78 /

-0.405 (-1.09%)

AGIO Agios Pharmaceuticals
$46.54 /

-0.19 (-0.41%)

ABMD Abiomed
$324.65 /

+0.28 (+0.09%)

ABMD Abiomed
$324.65 /

+0.28 (+0.09%)

12/21/20 SVB Leerink
Abiomed price target raised to $320 from $280 at SVB Leerink
12/14/20 Piper Sandler
Abiomed gets approval for XR sheath, says Piper Sandler
10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
08/07/20 SVB Leerink
Abiomed price target raised to $335 from $280 at SVB Leerink
AGIO Agios Pharmaceuticals
$46.54 /

-0.19 (-0.41%)

12/23/20 Citi
Agios shares 'significantly undervalued at this point,' says Citi
12/22/20 SVB Leerink
Agios Pharmaceuticals price target lowered to $51 from $61 at SVB Leerink
12/22/20 Cantor Fitzgerald
Agios oncology deal a positive read to FT-4202 strategy, says Cantor Fitzgerald
12/22/20 Barclays
Agios could enter 2022 with a third fewer shares, says Barclays
AHCO AdaptHealth
$36.78 /

-0.405 (-1.09%)

01/07/21 Canaccord
AdaptHealth price target raised to $50 from $39 at Canaccord
12/10/20 UBS
AdaptHealth initiated with a Buy at UBS
12/04/20 Deutsche Bank
AdaptHealth price target raised to $47 from $36 at Deutsche Bank
12/02/20 SVB Leerink
AdaptHealth price target raised to $39.50 from $32.50 at SVB Leerink
BCAB BioAtla
$41.38 /

+1.38 (+3.45%)

01/11/21 JPMorgan
BioAtla initiated with an Overweight at JPMorgan
01/11/21 Credit Suisse
BioAtla initiated with an Outperform at Credit Suisse
01/11/21 Jefferies
BioAtla initiated with a Buy at Jefferies
01/11/21 BTIG
BioAtla initiated with a Buy at BTIG
NXGN NextGen Healthcare
$20.50 /

+0.89 (+4.54%)

10/23/20 SVB Leerink
NextGen Healthcare price target raised to $14 from $12 at SVB Leerink
10/23/20 Piper Sandler
NextGen Healthcare price target lowered to $21 from $23 at Piper Sandler
07/31/20 Piper Sandler
NextGen Healthcare price target raised to $23 from $17 at Piper Sandler
06/02/20 Deutsche Bank
NextGen Healthcare price target lowered to $9 from $12 at Deutsche Bank
OLMA Olema Oncology
$41.97 /

+0.84 (+2.04%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
PCRX Pacira
$73.11 /

+1.46 (+2.04%)

01/06/21 RBC Capital
Pacira price target raised to $70 at RBC Capital, named one of 2021 top ideas
12/14/20 Barclays
Pacira price target raised to $79 from $73 at Barclays
09/30/20 Jefferies
Pacira price target raised to $75 from $69 at Jefferies
09/21/20 Northland
Pacira upgraded to Outperform on Exparel sales expectations at Northland
BIIB Biogen
$267.44 /

-0.13 (-0.05%)

01/11/21 Goldman Sachs
Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
12/04/20 Mizuho
Sage Therapeutics upgraded to Buy from Neutral at Mizuho
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
ESPR Esperion
$30.28 /

-1.01 (-3.23%)

11/10/20 Credit Suisse
Esperion upgraded to Outperform from Neutral at Credit Suisse
09/29/20 JPMorgan
Esperion resumed with an Underweight at JPMorgan
08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
EXEL Exelixis
$25.23 /

+1.1 (+4.56%)

12/14/20 William Blair
Calithera risk/reward attractive into CANTATA readout, says William Blair
10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
HQY HealthEquity
$75.95 /

+1.83 (+2.47%)

01/06/21 BTIG
HealthEquity initiated with a Neutral at BTIG
01/06/21 Deutsche Bank
HealthEquity price target raised to $77 from $60 at Deutsche Bank
12/08/20 Cantor Fitzgerald
HealthEquity price target raised to $77 from $70 at Cantor Fitzgerald
12/08/20 JPMorgan
HealthEquity price target raised to $72 from $61 at JPMorgan
MORF Morphic Holding
$30.12 /

+0.27 (+0.90%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

09/15/20 Cantor Fitzgerald
Cantor reiterates $70 target on Nano-X after 'unfounded' short report
09/15/20 Cantor Fitzgerald
Nano-X Imaging concerns in short report unfounded, says Cantor Fitzgerald
09/15/20 Oppenheimer
Nano-X Imaging initiated with a Perform at Oppenheimer
09/15/20 Berenberg
Nano-X Imaging initiated with a Buy at Berenberg
SRPT Sarepta
$87.32 /

-2.46 (-2.74%)

01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
01/11/21
Fly Intel: Top five analyst downgrades
01/11/21 UBS
Sarepta downgraded to Neutral on 'unexpected negative' results at UBS
01/11/21 UBS
Sarepta downgraded to Neutral from Buy at UBS
SHC Sotera Health
$25.20 /

-0.39 (-1.52%)

12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
12/15/20 Citi
Sotera Health initiated with a Buy at Citi
RVNC Revance
$29.47 /

+0.46 (+1.59%)

12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
11/25/20 H.C. Wainwright
H.C. Wainwright keeps Buy rating on Revance, says FDA news 'not surprising'
11/10/20 Mizuho
Revance price target lowered to $30 from $32 at Mizuho
10/26/20 Barclays
Revance price target raised to $38 from $35 at Barclays
RUBY Rubius Therapeutics
$9.16 /

+0.12 (+1.33%)

10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
03/13/20 Morgan Stanley
Morgan Stanley cuts Rubius to Equal Weight after discontinuation of PKU program
03/13/20 Guggenheim
Rubius Therapeutics price target lowered to $11 from $23 at Guggenheim
03/13/20 SVB Leerink
Rubius Therapeutics downgraded at SVB Leerink after RTX-134 discontinuation
ZYME Zymeworks
$53.99 /

-2.49 (-4.41%)

01/12/21 SVB Leerink
Zymeworks price target raised to $66 from $45 at SVB Leerink
01/12/21 Wells Fargo
Zymeworks price target raised to $71 from $58 at Wells Fargo
09/29/20 JPMorgan
Zymeworks resumed with a Neutral at JPMorgan
08/06/20
Fly Intel: Top analyst initiations
ZYME Zymeworks
$53.99 /

-2.49 (-4.41%)

SRPT Sarepta
$87.32 /

-2.46 (-2.74%)

SHC Sotera Health
$25.20 /

-0.39 (-1.52%)

RVNC Revance
$29.47 /

+0.46 (+1.59%)

RUBY Rubius Therapeutics
$9.16 /

+0.12 (+1.33%)

PCRX Pacira
$73.11 /

+1.46 (+2.04%)

NXGN NextGen Healthcare
$20.50 /

+0.89 (+4.54%)

NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

MORF Morphic Holding
$30.12 /

+0.27 (+0.90%)

HQY HealthEquity
$75.95 /

+1.83 (+2.47%)

EXEL Exelixis
$25.23 /

+1.1 (+4.56%)

ESPR Esperion
$30.28 /

-1.01 (-3.23%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

AHCO AdaptHealth
$36.78 /

-0.405 (-1.09%)

AGIO Agios Pharmaceuticals
$46.54 /

-0.19 (-0.41%)

ABMD Abiomed
$324.65 /

+0.28 (+0.09%)

  • 06
    Jan
  • 15
    Dec
  • 16
    Dec
  • 19
    Nov
  • 20
    Nov
  • 03
    Sep
  • 21
    Aug
  • 09
    Jul
  • 01
    Jul
  • 12
    Feb
  • 23
    Jan
NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

SRPT Sarepta
$87.32 /

-2.46 (-2.74%)

RVNC Revance
$29.47 /

+0.46 (+1.59%)

OLMA Olema Oncology
$41.97 /

+0.84 (+2.04%)

NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

HQY HealthEquity
$75.95 /

+1.83 (+2.47%)

ESPR Esperion
$30.28 /

-1.01 (-3.23%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

BCAB BioAtla
$41.38 /

+1.38 (+3.45%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

NNOX Nano-X Imaging
$51.61 /

+0.22 (+0.43%)

HQY HealthEquity
$75.95 /

+1.83 (+2.47%)

ESPR Esperion
$30.28 /

-1.01 (-3.23%)

BIIB Biogen
$267.44 /

-0.13 (-0.05%)

AHCO AdaptHealth
$36.78 /

-0.405 (-1.09%)

Hot Stocks
One Medical extends public COVID-19 vaccination effors » 09:02
01/12/21
01/12
09:02
01/12/21
09:02
ONEM

1Life Healthcare

$41.52 /

-1.16 (-2.72%)

One Medical announced it…

One Medical announced it is continuing to expand its COVID-19 vaccination efforts nationwide, now offering support for community vaccinations in New York City, Los Angeles, Seattle, and the greater San Francisco Bay Area, with plans for more geographies soon. With limited quantities of vaccines currently being provided by local departments of public health, One Medical is administering doses to Phase 1a and select Phase 1b populations in accordance with guidance from local, state and federal health officials. One Medical is also providing complimentary telehealth services to qualifying patients referred by departments of public health during the course of vaccination services, leveraging One Medical's technology platform for vaccine appointment scheduling, second dose vaccine reminders, digital health follow up through video chats and messaging, and data reporting.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$41.52 /

-1.16 (-2.72%)

ONEM 1Life Healthcare
$41.52 /

-1.16 (-2.72%)

01/08/21 Piper Sandler
1Life Healthcare price target raised to $51 from $44 at Piper Sandler
01/07/21 Canaccord
1Life Healthcare price target raised to $50 from $46 at Canaccord
01/06/21 BTIG
1Life Healthcare initiated with a Neutral at BTIG
12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
ONEM 1Life Healthcare
$41.52 /

-1.16 (-2.72%)

  • 23
    Nov
  • 25
    Jun
  • 31
    Jan
ONEM 1Life Healthcare
$41.52 /

-1.16 (-2.72%)

ONEM 1Life Healthcare
$41.52 /

-1.16 (-2.72%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.